Is Jardiance a GLP-1? No — Here's the Difference

Quick answer: No — Jardiance (empagliflozin) is not a GLP-1. It belongs to a different family of drugs called SGLT2 inhibitors, which work in the kidneys, while GLP-1 medications work through gut hormones that slow digestion and quiet appetite. They’re two different tools for the same problem, and some people end up taking both.

The confusion is understandable. Jardiance and drugs like Ozempic arrived around the same era, both show up in commercials with cheerful music and heart-health claims, both can lower blood sugar and help with weight, and both get prescribed alongside metformin. But “Jardiance” and “GLP-1” describe different mechanisms inside your body — and knowing which one you’re on changes what side effects to expect, what questions to ask, and what “working” looks like.

If it’s not a GLP-1, what is Jardiance?

Jardiance is an SGLT2 inhibitor — a drug that works in your kidneys, not your gut or pancreas (source: MedlinePlus (NIH)). Here’s the plain-language version of the job: your kidneys filter your blood all day, and normally they reclaim almost all the glucose they filter and send it back into the blood. SGLT2 inhibitors block the part of the kidney that does the reclaiming. The result is that extra glucose — extra sugar — leaves your body in urine instead of staying in your blood.

That’s a plumbing change, not a hormone change. It works whether your insulin levels are high, low, or anywhere in between, which is one reason it can be added to almost any diabetes regimen. Two side effects come straight from the mechanism: because sugar is passing through urine, sugar feeds yeast and bacteria on the way out, so urinary tract infections and genital yeast infections are the known trade-offs. And because you’re losing fluid along with glucose, staying hydrated matters.

SGLT2 inhibitors also turned out to have heart and kidney benefits that go beyond blood sugar — a big reason doctors reach for them in people with heart failure or chronic kidney disease, even when glucose numbers aren’t the main problem.

So what makes a drug a GLP-1?

GLP-1 medications (Ozempic, Mounjaro, Wegovy, Trulicity, and others) copy a hormone your gut releases after you eat. That hormone does three things at once: it prompts your pancreas to release insulin when glucose is high, it slows how fast food leaves your stomach, and it signals fullness to your brain. The appetite and digestion effects are why GLP-1s tend to produce larger weight loss than SGLT2 inhibitors — smaller portions and slower eating are built into the mechanism itself, whereas Jardiance’s weight effect is mostly calories leaving in urine.

The side-effect profiles differ for the same reason. GLP-1s are mostly digestive at the start — nausea is the most common complaint, especially during dose increases. Jardiance doesn’t cause nausea the same way; its issues are the urinary and yeast infections mentioned above, plus a rare but serious one called euglycemic ketoacidosis, where acid builds up in the blood even though glucose readings look normal or only mildly high. Warning signs include nausea, vomiting, stomach pain, unusual tiredness, and trouble breathing — and those are call-the-doctor-today symptoms, not wait-a-few-days ones.

Why do people confuse Jardiance with GLP-1s?

Four honest reasons:

• Same era, same aisle. Both families became prominent in the last decade, and both show up in direct-to-consumer ads aimed at the same audience.
• Overlapping benefits. Both lower A1c, both can help with weight, and both carry extra heart benefits — so the headlines sound interchangeable even though the mechanisms are not.
• Shared vocabulary. “Newer diabetes drug with heart benefits” describes both, so people hear one description and file it under the other name.
• Combination therapy. Some people genuinely take a GLP-1 and an SGLT2 inhibitor at the same time, because they pull different levers and the effects add up. If a friend takes both, it’s easy to conclude they’re the same thing.

The full drug-family picture — where metformin, sulfonylureas, GLP-1s, SGLT2s, and insulin each fit — is in our plain-language guide to type 2 diabetes medications, and the GLP-1 side in more depth in our guide to GLP-1 medications.

Jardiance vs. GLP-1 at a glance

One note on the table: it compares families, not individuals. Your prescriber isn’t picking “which drug is better” in the abstract — they’re picking what fits your kidneys, your heart, your weight goals, your other medications, and your insurance.

How do you know which one you’re on?

Ask yourself two questions. First, is it a pill or an injection? Jardiance is a once-daily tablet; most GLP-1s are weekly or daily injections, though a few pills now exist, so this doesn’t settle it alone. Second, and more reliable: check the generic name on the bottle. Empagliflozin, dapagliflozin, and canagliflozin are SGLT2 inhibitors. Semaglutide, tirzepatide, dulaglutide, and liraglutide are GLP-1s. The generic name tells you the family; the family tells you what to expect.

If you’re ever unsure, your pharmacist can tell you in one sentence — and knowing the answer matters for practical reasons. GLP-1 nausea management, sick-day rules, and dose-timing questions don’t apply to Jardiance, while Jardiance’s hydration and yeast-infection concerns don’t apply to a GLP-1. Mixed-up expectations lead to missed warning signs.

What should you watch for on Jardiance?

Most side effects are manageable, but three situations deserve fast attention:

• Signs of ketoacidosis — nausea, vomiting, stomach pain, unusual tiredness, trouble breathing — even when your glucose readings look normal or only slightly high. This is the rare-but-serious one specific to SGLT2 inhibitors, and it needs same-day medical contact.
• Genital or urinary symptoms that don’t clear up: burning, discharge, or repeated infections. These are common and treatable, but they shouldn’t be ignored for months.
• Dehydration — dizziness when standing, dark urine, dry mouth. Especially in hot weather, during illness, or if you also take a diuretic or a blood-pressure medication, the fluid loss from this drug family adds up.

Should you ask your prescriber to switch?

Only if your reasons are concrete, not because one drug is in the news more than the other. Legitimate reasons sound like: recurring infections that make the SGLT2 hard to live with, weight goals that the current drug isn’t addressing, kidney or heart findings that changed the calculus, or affordability. The wrong reason is expecting a GLP-1 to duplicate what your current drug does — it won’t, because it does a different job.

Worth asking at your next visit: what is this medication protecting besides my blood sugar? Given my kidneys and heart, is this still the right family? And if we ever added a second drug, which family would you pick and why? Those three questions usually produce a clearer answer than any comparison table.

Can you take Jardiance and a GLP-1 together?

Yes, and it’s a real, common combination — but it’s your doctor’s decision, not something to arrange yourself. The two families work at completely different points: the GLP-1 changes how your body handles glucose after food, the SGLT2 changes what your kidneys do with it all day. Used together they can lower A1c more than either alone, and some studies suggest added heart and kidney benefit from the pairing.

The trade-off to discuss before starting both: mild dehydration risk goes up, since the SGLT2 increases fluid loss through urine and the GLP-1 can cause vomiting early on. If you’re on the combination, fluids matter, and sick-day rules (what to pause and who to call when you can’t keep food or drink down) are worth getting in writing before you need them.

Frequently asked questions

Is Jardiance a GLP-1? No. Jardiance (empagliflozin) is an SGLT2 inhibitor — it works in the kidneys by flushing extra glucose into urine. GLP-1 drugs work through gut hormones that affect insulin release, digestion, and appetite. Different mechanisms, different families.

Does Jardiance cause weight loss like Ozempic? Jardiance often produces modest weight loss because calories leave the body in urine. It’s usually much smaller than what GLP-1s produce, since GLP-1s directly reduce appetite and portion sizes.

What are the main side effects of Jardiance? Urinary tract infections and genital yeast infections are the most common, because glucose in urine feeds yeast and bacteria. Rare but serious: euglycemic ketoacidosis — nausea, vomiting, belly pain, or trouble breathing needs a call to your doctor, even when glucose looks normal.

Can I take Jardiance and Ozempic together? Yes — it’s a common combination that many prescribers use, because the two drug families lower glucose through different mechanisms. Whether it’s right for you depends on your kidneys, heart, other medications, and risk of dehydration, so it’s a prescriber’s call.

Why do doctors prescribe Jardiance if my blood sugar isn’t the main problem? Because SGLT2 inhibitors have proven benefits for heart failure and chronic kidney disease beyond glucose control. Your doctor may choose Jardiance to protect your heart or kidneys even when A1c isn’t the primary concern.

This guide is also available in Spanish: ¿Jardiance es un GLP-1? No — esta es la diferencia.

Full Guide

Educational content only — not a substitute for advice from your doctor or pharmacist. Always work with your care team.